“Bio 3D Printer” with One-of-a-Kind Technology

The Bio 3D Printer by Cyfuse is equipped with our proprietary Bio 3D Printing platform technology. The platform technology, created by leveraging the strengths of the Cyfuse fusion of biology and engineering, is applicable to a diverse array of cells, and the subsequent development and product commercialization of the Bio 3D Printer have been followed by breakthroughs in regenerative medicine and drug discovery research in a broad range of disease areas.

Cyfuse is involved in development aimed at putting 3D cellular products produced by the Bio 3D Printer into practical use as regenerative medical products for the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves, and is also moving forward with development aimed at practical use in the form of disease models for elucidating the mechanisms of various diseases, as well as drug discovery screening tools for evaluating the efficacy, toxicity, and metabolites, for example, of new drugs.
Cyfuse also in-sources both researchers and engineers in the fields of biology and engineering to provide one-stop solutions for a variety of technical R&D needs via the dissemination of technologies based on the Bio 3D Printer as well as the global expansion of technical R&D based on this platform technology.